| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.51% | 1.50% | -10.76% | -1.98% | 1.30% | 81 280 |
| REGENERON PHARMACEUTICALS, INC. | 1.37% | 4.79% | 9.70% | 37.89% | 124.99% | 74 647 |
| VERTEX PHARMACEUTICALS | 1.51% | 5.85% | 24.65% | 31.20% | 58.45% | 70 008 |
| BIONTECH SE | 5.57% | 2.43% | -35.24% | -18.16% | --.--% | 40 574 |
 | WUXI APPTEC CO., LTD. | 4.97% | -5.16% | -22.01% | -34.41% | 170.57% | 39 958 |
 | GENMAB A/S | -0.61% | -0.71% | -19.73% | -15.39% | 73.53% | 19 916 |
 | ARGENX SE | 2.25% | -1.64% | -4.76% | 30.28% | 151.72% | 17 577 |
| BEIGENE, LTD. | 2.06% | -2.45% | -50.56% | -62.63% | 8.81% | 13 822 |
| NEUROCRINE BIOSCIENCES, INC. | 3.63% | 8.03% | 9.31% | -3.24% | 17.21% | 8 898 |
| HALOZYME THERAPEUTICS, INC. | 3.65% | 6.30% | 20.12% | 16.64% | 221.14% | 6 654 |
| LEGEND BIOTECH CORPORATION | 8.59% | 0.28% | -8.32% | 8.53% | --.--% | 6 590 |
| SAREPTA THERAPEUTICS, INC. | 5.29% | 4.95% | -17.10% | -1.32% | -39.17% | 6 532 |
| EXELIXIS, INC. | 1.15% | 3.60% | 0.66% | -18.40% | -8.14% | 5 902 |
| INTRA-CELLULAR THERAPIES, INC. | -0.75% | 0.69% | 11.35% | 47.88% | 347.62% | 5 497 |
 | BIOCON LIMITED | 2.34% | -2.06% | -8.68% | -12.80% | 20.89% | 5 106 |
| | | | | | | |
| | Media | 2.77% | 1.76% | -6.76% | 0.27% | 88.38% | |
| | Media ponderata per Capi. | 2.21% | 2.15% | -4.56% | 5.75% | 78.51% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
